Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury-Reference-Cited by-同舟云学术

Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury

Published:2022-03-16 Issue:4 Volume:5 Page:207-215
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Long Keith,Vaughn Zoe,McDaniels Michael David^ORCID,Joyasawal Sipak^ORCID,Przepiorski Aneta,Parasky Emily,Sander Veronika¹^ORCID,Close David,Johnston Paul A.,Davidson Alan J.¹,de Caestecker Mark²,Hukriede Neil A.^ORCID,Huryn Donna M.^ORCID

Affiliation:

1. Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand 1010

2. Department of Medicine, Division of Nephrology, Vanderbilt University, Nashville, Tennessee 37235, United States

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

U.S. Department of Defense

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.1c00243

Reference37 articles.

1. Acute kidney injury

2. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup

3. Long-term consequences of acute kidney injury: a narrative review

4. Drugs in Development for Acute Kidney Injury

5. Therapeutic effects of histone deacetylase inhibitors on kidney disease

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Replacement of the hydroxamic acid group in the selective HDAC8 inhibitor PCI-34051;Bioorganic & Medicinal Chemistry Letters;2024-08

2. A comprehensive review on 3D tissue models: Biofabrication technologies and preclinical applications;Biomaterials;2024-01

3. Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening;Journal of Biomolecular Structure and Dynamics;2022-11-12

4. Virtual Special Issue: Epigenetics 2022;ACS Chemical Biology;2022-10-21

5. Virtual Special Issue: Epigenetics 2022;ACS Medicinal Chemistry Letters;2022-10-13